Point Partners LLC,0.483522
drug-resistant infectious diseases,-0.605889
clinical-stage biopharmaceutical company,0.298413
life-threatening multidrug-resistant infections,-0.766748
stock,0.356036
related companies,0.566987
InvestorPlace Broker Center,0.555736
oral antibiotic,-0.475525
MarketBeat Ratings reports,-0.220137
high fees,-0.735674
research report,0.285685
biopharmaceutical company,0.435456
equities analysts,-0.286064
sell rating,0.376194
Zacks Investment Research,0.40995
personal trading style,0.598412
chemistry technology,-0.766748
average rating,-0.253601
life science company,-0.605889
target price,0.324402
Pharmaceuticals Inc Daily,0.397938
tetracycline based drugs,-0.605889
research offerings,0.40995
shares,0.463657
concise daily summary,0.505807
consensus target price,0.440552
Tetraphase Pharmaceuticals,0.107298
Gram-negative infections,-0.475525
Great Point Partners,0.483522
stock broker,0.245696
equities research analyst,0.376194
quarterly earnings data,-0.221838
quarter,0.483522
